Hip Scope Fascia-iliaca (FI) Block Study

The Hawkins Foundation84 enrolled

Overview

Patients undergoing a hip scope procedure will be recruited for this study. They will be randomized to either receive a nerve block or no nerve block (pain medicine only). Pain levels and clinical outcomes will be assessed through 3 months post-operatively.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Hip Dysplasia Femoroacetabular Impingement Acetabular Labrum Tear

Interventions

ropivicaineDRUG

clonidineDRUG

EpinephrineDRUG

NoropinDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Scheduled for outpatient hip arthroscopy * American Society of Anesthesiologists (ASA) 1-3 Exclusion Criteria: * Prior surgery on ipsilateral hip * ASA 4-6 * Chronic narcotic usage over 6 months or more than the equivalent of 20mg of morphine per day * Current or prior placement of a spinal cord stimulator or intrathecal pump for pain control purposes * Allergy to amide local anesthetics * Contraindication to regional anesthesia * BMI \> 40 * Females who are pregnant or plan to get pregnant during the course of the study

Locations (1)

Steadman Hawkins Clinic of the Carolinas - Greenville Health System

Greenville, South Carolina, United States

Outcomes

Primary Outcomes

Visual Analog Scale

Pain, as measured by Visual Analog Scale (VAS). Scores are ranged from 0-10, 0 is no pain and 10 is worst possible pain. The unit of measure is units on a scale.

Time frame: 3 Months

Secondary Outcomes

Opioid Consumption

Opioid consumption, as measured by narcotic usage (morphine milligram equivalents)

Time frame: 3 Months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.